Plasmodium vivax. Modern Strategies to Study a Persistent Parasite's Life Cycle

Advances in Parasitology

Volumn 81, Issue , 2013, Pages 1-26

  Galinski, Mary R ^a,b   Meyer, Esmeralda V S ^b   Barnwell, John W ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Life cycle; Malaria parasite species; Parasite; Plasmodium vivax; Primates

Indexed keywords

ARTICLE; EX VIVO STUDY; HOST PARASITE INTERACTION; HUMAN; IN VITRO STUDY; LIVER DEVELOPMENT; NONHUMAN; PLASMODIUM; PLASMODIUM (LIFE CYCLE STAGE); PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; RETICULOCYTE; SEXUAL BEHAVIOR; SYSTEMS BIOLOGY;

EID: 84873115659     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-407826-0.00001-1     Document Type: Chapter

References (130)

1. Acharya P., et al. A glimpse into the clinical proteome of human malaria parasites Plasmodium falciparum and Plasmodium vivax. Proteomics Clin. Appl. 2009, 3(11):1314-1325.
2. Acharya P., et al. Clinical proteomics of the neglected human malarial parasite Plasmodium vivax. PLoS One 2011, 6(10):e26623.
3. Aguas R., Ferreira M.U., Gomes M.G. Modeling the effects of relapse in the transmission dynamics of malaria parasites. J. Parasitol. Res. 2012, 921715.
4. Aikawa M., Miller L.H., Rabbege J. Caveola-vesicle complexes in the plasmalemma of erythrocytes infected by Plasmodium vivax and P cynomolgi. Unique structures related to Schuffner's dots. Am. J. Pathol. 1975, 79(2):285-300.
5. Akinyi S., et al. A 95 kDa protein of Plasmodium vivax and P. cynomolgi visualized by three-dimensional tomography in the caveola-vesicle complexes (Schuffner's dots) of infected erythrocytes is a member of the PHIST family. Mol. Microbiol. 2012, 84(5):816-831.
6. Altevogt B.M., et al. Research agenda. Guiding limited use of chimpanzees in research. Science 2012, 335(6064):41-42.
7. Arevalo-Herrera M., et al. Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America. Mem. Inst. Oswaldo Cruz 2011, 106(Suppl. 1):202-211.
8. Baer K., et al. Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog. 2007, 3(11):e171.
9. Baer K., et al. Kupffer cells are obligatory for Plasmodium yoelii sporozoite infection of the liver. Cell. Microbiol. 2007, 9(2):397-412.
10. Barnwell J.W., et al. Plasmodium vivax: malarial proteins associated with the membrane-bound caveola-vesicle complexes and cytoplasmic cleft structures of infected erythrocytes. Exp. Parasitol. 1990, 70(1):85-99.
11. Barnwell J.W., Nichols M.E., Rubinstein P. In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J. Exp. Med. 1989, 169(5):1795-1802.
12. Baruch D.I., et al. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 1995, 82(1):77-87.
13. Bass C.C., Johns F.M. The cultivation of malarial Plasmodia (Plasmodium vivax and Plasmodium falciparum) in vitro. J. Exp. Med. 1912, 16(4):567-579.
14. Borlon C., et al. Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture. Int. J. Parasitol. 2012, 42(2):155-160.
15. Bousema T., Drakeley C. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin. Microbiol. Rev. 2011, 24(2):377-410.
16. Boyd M., Stratman-Thomas W., Kitchen S. On the relative susceptibility of Anopheles quadrimaculatus to Plasmodium vivax and Plasmodium falciparum. Am. J. Trop. Med. Hyg. 1935, s1-15(4):485-493.
17. Boyd M., Stratman-Thomas W., Muench H. The occurrence of gametocytes of Plasmodium vivax during the primary attack. Am. J. Trop. Med. Hyg. 1936, s1-16:133-138.
18. Boyd M.F., Andstratman-Thomaws K. Studies on Plasmodium vivax. 7. Some observations on inoculation and onset. Am. J. Hyg. 1934, 20:488.
19. Bozdech Z., et al. The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc. Natl. Acad. Sci. U S A 2008, 105(42):16290-16295.
20. Bray R.S., et al. Observations on early and late post-sporozoite tissue stages in primate malaria. III. Further attempts to find early forms and to correlate hypnozoites with growing exo-erythrocytic schizonts and parasitaemic relapses in Plasmodium cynomolgi bastianellii infections. Trans. R Soc. Trop. Med. Hyg. 1985, 79(2):269-273.
21. Bruce M.C., et al. Commitment of the malaria parasite Plasmodium falciparum to sexual and asexual development. Parasitology 1990, 100(Pt 2):191-200.
22. Carlton J.M., et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 2008, 455(7214):757-763.
23. Carlton J.M., et al. Comparative evolutionary genomics of human malaria parasites. Trends Parasitol. 2008, 24(12):545-550.
24. Carlton J.M., Sina B.J., Adams J.H. Why is Plasmodium vivax a neglected tropical disease?. PLoS Negl. Trop. Dis. 2011, 5(6):e1160.
25. Carter R., Miller L.H. Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture. Bull. World Health Organ. 1979, 57(Suppl. 1):37-52.
26. Carter R., Nijhout M.M. Control of gamete formation (exflagellation) in malaria parasites. Science 1977, 195(4276):407-409.
27. Carvalho B.O., et al. On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J. Infect. Dis. 2010, 202(4):638-647.
28. Cavasini C.E., et al. Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception?. Trans. R Soc. Trop. Med. Hyg. 2007, 101(10):1042-1044.
29. Chamchod F., Beier J.C. Modeling Plasmodium vivax: relapses, treatment, seasonality, and G6PD deficiency. J. Theor. Biol. 2012.
30. Chan E.R., et al. Whole genome sequencing of field isolates provides robust characterization of genetic diversity in Plasmodium vivax. PLoS Negl. Trop. Dis. 2012, 6(9):e1811.
31. Chattopadhyay R., et al. Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria. PLoS One 2010, 5(12):e14275.
32. Chen N., et al. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J. Infect. Dis. 2007, 195(7):934-941.
33. Chitnis C.E., Miller L.H. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J. Exp. Med. 1994, 180(2):497-506.
34. Coatney G.R. The Primate Malarias 1971, US Government Printing Office, Washington, DC.
35. Cogswell F.B. The hypnozoite and relapse in primate malaria. Clin. Microbiol. Rev. 1992, 5(1):26-35.
36. Cogswell F.B., et al. Hypnozoites of Plasmodium simiovale. Am. J. Trop. Med. Hyg. 1991, 45(2):211-213.
37. Collins W.E., Contacos P.G. Infection and transmission studies with Plasmodium simiovale in the Macaca mulatta monkey. J. Parasitol. 1979, 65(4):609-612.
38. Collins W.E., Contacos P.G. Observations on the relapse activity of Plasmodium simiovale in the rhesus monkey. J. Parasitol. 1974, 60(2):343.
39. Collins W.E., Contacos P.G., Jumper J.R. Studies on the exoerythrocytic stages of simian malaria. VII. Plasmodium simiovale. J. Parasitol. 1972, 58(1):135-141.
40. Collins W.E., et al. Studies on the Salvador I strain of Plasmodium vivax in non-human primates and anopheline mosquitoes. Am. J. Trop. Med. Hyg. 2009, 80(2):228-235.
41. Daily J.P., et al. Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature 2007, 450(7172):1091-1095.
42. Deane L.M., Deane M.P., Ferreira Neto J. Studies on transmission of simian malaria and on a natural infection of man with Plasmodium simium in Brazil. Bull. World Health Organ. 1966, 35(5):805-808.
43. del Portillo H.A., et al. A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax. Nature 2001, 410(6830):839-842.
44. Dembele L., et al. Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery. PLoS One 2011, 6(3):e18162.
45. Deye G.A., et al. Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances. Am. J. Trop. Med. Hyg. 2012, 86(6):931-935.
46. Dharia N.V., et al. Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genes. Proc. Natl. Acad. Sci. U S A 2010, 107(46):20045-20050.
47. Dissanaike A.S. Simian malaria parasites of Ceylon. Bull. World Health Organ. 1965, 32:593-597.
48. Ejigiri I., Sinnis P. Plasmodium sporozoite-host interactions from the dermis to the hepatocyte. Curr. Opin. Microbiol. 2009, 12(4):401-407.
49. Escalante A.A., et al. A monkey's tale: the origin of Plasmodium vivax as a human malaria parasite. Proc. Natl. Acad. Sci. U S A 2005, 102(6):1980-1985.
50. Frevert U., et al. Plasmodium sporozoite passage across the sinusoidal cell layer. Subcell Biochem. 2008, 47:182-197.
51. Galinski M.R., Barnwell J. Nonhuman primate models for human malaria research. Nonhuman Primates in Biomedical Research: Diseases 2012, 299-323. Academic Press Elsevier. C.R. Abee (Ed.).
52. Galinski M.R., Barnwell J.W. Plasmodium vivax: merozoites, invasion of reticulocytes and considerations for malaria vaccine development. Parasitol. Today 1996, 12(1):20-29.
53. Galinski M.R., Barnwell J.W. Plasmodium vivax: who cares?. Malar. J. 2008, 7(Suppl. 1):S9.
54. Galinski M.R., et al. A reticulocyte-binding protein complex of Plasmodium vivax merozoites. Cell 1992, 69(7):1213-1226.
55. Galinski M.R., Xu M., Barnwell J.W. Plasmodium vivax reticulocyte binding protein-2 (PvRBP-2) shares structural features with PvRBP-1 and the Plasmodium yoelii 235 kDa rhoptry protein family. Mol. Biochem. Parasitol. 2000, 108(2):257-262.
56. Gardner M.J., et al. Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14. Nature 2002, 419(6906):531-534.
57. Garnham P.C., et al. A strain of Plasmodium vivax characterized by prolonged incubation: morphological and biological characteristics. Bull. World Health Organ 1975, 52(1):21-32.
58. Gething P.W., et al. A long neglected World malaria map: Plasmodium vivax Endemicity in 2010. PLoS Negl. Trop. Dis. 2012, 6(9):e1814.
59. Gething P.W., et al. Modelling the global constraints of temperature on transmission of Plasmodium falciparum and P. vivax. Parasit. Vectors 2011, 4:92.
60. Golenda C.F., Li J., Rosenberg R. Continuous in vitro propagation of the malaria parasite Plasmodium vivax. Proc. Natl. Acad. Sci. U S A 1997, 94(13):6786-6791.
61. Grimberg B.T., et al. Increased reticulocyte count from cord blood samples using hypotonic lysis. Exp. Parasitol. 2012, 132(2):304-307.
62. Grimberg B.T., et al. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med. 2007, 4(12):e337.
63. Guilbride D.L., Guilbride P.D., Gawlinski P. Malaria's deadly secret: a skin stage. Trends Parasitol. 2012, 28(4):142-150.
64. Handayani S., et al. High deformability of Plasmodium vivax-infected red blood cells under microfluidic conditions. J. Infect. Dis. 2009, 199(3):445-450.
65. Haynes J.D., et al. Culture of human malaria parasites Plasmodium falciparum. Nature 1976, 263(5580):767-769.
66. Hollingdale M.R., et al. In vitro culture of two populations (dividing and nondividing) of exoerythrocytic parasites of Plasmodium vivax. Am. J. Trop. Med. Hyg. 1985, 34(2):216-222.
67. Imwong M., et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J. Infect. Dis. 2007, 195(7):927-933.
68. Jiang J.B., et al. Observations on early and late post-sporozoite tissue stages in primate malaria. V. The effect of pyrimethamine and proguanil upon tissue hypnozoites and schizonts of Plasmodium cynomolgi bastianellii. Trans. R Soc. Trop. Med. Hyg. 1988, 82(1):56-58.
69. Jones D.P., Park Y., Ziegler T.R. Nutritional metabolomics: progress in addressing complexity in diet and health. Annu. Rev. Nutr. 2012, 32:183-202.
70. Kafsack B.F., Llinas M. Eating at the table of another: metabolomics of host-parasite interactions. Cell Host Microbe. 2010, 7(2):90-99.
71. Kitchen S.F. The infection of reticulocytes by Plasmodium vivax. Am. J. Trop. Med. 1938, 18:347-359.
72. Kosaisavee V., et al. The genetic polymorphism of Plasmodium vivax genes in endemic regions of Thailand. Asian Pac. J. Trop. Med. 2011, 4(12):931-936.
73. Krotoski W.A., et al. Observations on early and late post-sporozoite tissue stages in primate malaria. II. The hypnozoite of Plasmodium cynomolgi bastianellii from 3 to 105 days after infection, and detection of 36- to 40-hour pre-erythrocytic forms. Am. J. Trop. Med. Hyg. 1982, 31(2):211-225.
74. Krotoski W.A., et al. Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. Am. J. Trop. Med. Hyg. 1982, 31(6):1291-1293.
75. Krotoski W.A., et al. Observations on early and late post-sporozoite tissue stages in primate malaria. I. Discovery of a new latent form of Plasmodium cynomolgi (the hypnozoite), and failure to detect hepatic forms within the first 24 hours after infection. Am. J. Trop. Med. Hyg. 1982, 31(1):24-35.
76. Krotoski W.A., et al. Observations on early and late post-sporozoite tissue stages in primate malaria. IV. Pre-erythrocytic schizonts and/or hypnozoites of Chesson and North Korean strains of Plasmodium vivax in the chimpanzee. Am. J. Trop. Med. Hyg. 1986, 35(2):263-274.
77. Krotoski W.A., et al. Relapses in primate malaria: discovery of two populations of exoerythrocytic stages. Preliminary note. Br. Med. J. 1980, 280(6208):153-154.
78. Kuss C., et al. Quantitative proteomics reveals new insights into erythrocyte invasion by Plasmodium falciparum. Mol. Cell. Proteomics 2012, 11(2):M111010645.
79. Lacerda M.V., et al. Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Malar. J. 2012, 11:12.
80. LaCount D.J., et al. A protein interaction network of the malaria parasite Plasmodium falciparum. Nature 2005, 438(7064):103-107.
81. Lanners H.N. Prolonged in vitro cultivation of Plasmodium vivax using Trager's continuous-flow method. Parasitol. Res. 1992, 78(8):699-701.
82. Lasonder E., et al. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature 2002, 419(6906):537-542.
83. Lasonder E., et al. Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity. PLoS Pathog. 2008, 4(10):e1000195.
84. Le Roch K.G., Chung D.W., Ponts N. Genomics and integrated systems biology in Plasmodium falciparum: a path to malaria control and eradication. Parasite Immunol. 2012, 34(2-3):50-60.
85. Li J., Han E.T. Dissection of the Plasmodium vivax reticulocyte binding-like proteins (PvRBPs). Biochem. Biophys. Res. Commun. 2012, 426(1):1-6.
86. Mazier D., et al. Cultivation of the liver forms of Plasmodium vivax in human hepatocytes. Nature 1984, 307(5949):367-369.
87. Meis J.F., et al. Malaria parasites-discovery of the early liver form. Nature 1983, 302(5907):424-426.
88. Menard D., et al. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc. Natl. Acad. Sci. U S A 2010, 107(13):5967-5971.
89. Mons B. Preferential invasion of malarial merozoites into young red blood cells. Blood Cells 1990, 16(2-3):299-312.
90. Mons B., et al. Plasmodium vivax: in vitro growth and reinvasion in red blood cells of Aotus nancymai. Exp. Parasitol. 1988, 66(2):183-188.
91. Mons B., et al. Erythrocytic schizogony and invasion of Plasmodium vivax in vitro. Int. J. Parasitol. 1988, 18(3):307-311.
92. Mu J., et al. Host switch leads to emergence of Plasmodium vivax malaria in humans. Mol. Biol. Evol. 2005, 22(8):1686-1693.
93. Mueller I., et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect. Dis. 2009, 9(9):555-566.
94. Nguyen-Dinh P., et al. Cultivation in vitro of the vivax-type malaria parasite Plasmodium cynomolgi. Science 1981, 212(4499):1146-1148.
95. Noulin F., et al. Cryopreserved reticulocytes derived from hematopoietic stem cells can be invaded by cryopreserved Plasmodium vivax isolates. PLoS One 2012, 7(7):e40798.
96. Pacheco M.A., et al. Evidence of purifying selection on merozoite surface protein 8 (MSP8) and 10 (MSP10) in Plasmodium spp. Infect. Genet. Evol. 2012.
97. Pain A., et al. The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature 2008, 455(7214):799-803.
98. Panichakul T., et al. Production of erythropoietic cells in vitro for continuous culture of Plasmodium vivax. Int. J. Parasitol. 2007, 37(14):1551-1557.
99. Pfahler J.M., et al. Transient transfection of Plasmodium vivax blood stage parasites. Mol. Biochem. Parasitol. 2006, 149(1):99-101.
100. Pradel G., Frevert U. Malaria sporozoites actively enter and pass through rat Kupffer cells prior to hepatocyte invasion. Hepatology 2001, 33(5):1154-1165.
101. Prasad C.S., Aparna N., Harendra Kumar M.L. Exflagellated microgametes of Plasmodium vivax in human peripheral blood: an uncommon feature of malaria. Indian J. Hematol. Blood Transfus. 2011, 27(2):104-106.
102. Price R.N., et al. Plasmodium vivax treatments: what are we looking for?. Curr. Opin. Infect. Dis. 2011, 24(6):578-585.
103. Prudencio M., Rodriguez A., Mota M.M. The silent path to thousands of merozoites: the Plasmodium liver stage. Nat. Rev. Microbiol. 2006, 4(11):849-856.
104. Ray S., et al. Serum proteome analysis of vivax malaria: an insight into the disease pathogenesis and host immune response. J. Proteomics 2012, 75(10):3063-3080.
105. Reininger L., et al. The Plasmodium falciparum, Nima-related kinase Pfnek-4: a marker for asexual parasites committed to sexual differentiation. Malar. J. 2012, 11(1):250.
106. Richter J., et al. What is the evidence for the existence of Plasmodium ovale hypnozoites?. Parasitol. Res. 2010, 107(6):1285-1290.
107. Roobsoong W., et al. Characterization of the Plasmodium vivax erythrocytic stage proteome and identification of a potent immunogenic antigen of the asexual stages. Malar. J. 2010, 9.
108. Roobsoong W., et al. Determination of the Plasmodium vivax schizont stage proteome. J. Proteomics 2011, 74(9):1701-1710.
109. Russell B., et al. A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax. Blood 2011, 118(13):e74-81.
110. Russell B.M., et al. Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob. Agents Chemother. 2003, 47(1):170-173.
111. Ryan J.R., et al. Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya. Am. J. Trop. Med. Hyg. 2006, 75(4):575-581.
112. Schmidt L.H. Relationships between chemical structures of 8-aminoquinolines and their capacities for radical cure of infections with Plasmodium cynomolgi in rhesus monkeys. Antimicrob. Agents Chemother. 1983, 24(5):615-652.
113. Shortt H.E., Garnham P.C. Demonstration of a persisting exo-erythrocytic cycle in Plasmodium cynomolgi and its bearing on the production of relapses. Br. Med. J. 1948, 1(4564):1225-1228.
114. Shortt H.E., Garnham P.C., et al. The pre-erythrocytic stage of human malaria, Plasmodium vivax. Br. Med. J. 1948, 1(4550):547.
115. Silvestrini F., Alano P., Williams J.L. Commitment to the production of male and female gametocytes in the human malaria parasite Plasmodium falciparum. Parasitology 2000, 121(Pt 5):465-471.
116. Sinnis P., Zavala F. The skin stage of malaria infection: biology and relevance to the malaria vaccine effort. Future Microbiol. 2008, 3(3):275-278.
117. Smalley M.E., Abdalla S., Brown J. The distribution of Plasmodium falciparum in the peripheral blood and bone marrow of Gambian children. Trans. R. Soc. Trop. Med. Hyg. 1980, 75:103-105.
118. Smith J.D., et al. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 1995, 82(1):101-110.
119. Su X.Z., et al. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell 1995, 82(1):89-100.
120. Tachibana S., et al. Plasmodium cynomolgi genome sequences provide insight into Plasmodium vivax and the monkey malaria clade. Nat. Genet. 2012, 44(9):1051-1055.
121. Thiberge S., et al. In vivo imaging of malaria parasites in the murine liver. Nat. Protoc. 2007, 2(7):1811-1818.
122. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science 1976, 193(4254):673-675.
123. Udagama P.V., Atkinson C.T., Peiris J.S., David P.H., Mendis K.N., Aikawa M. Immunoelectron microscopy of Schüffner's dots in Plasmodium vivax-infected human erythrocytes. Am. J. Pathol. 1988, 131(1):48-52.
124. Udomsangpetch R., et al. Cultivation of Plasmodium vivax. Trends Parasitol. 2008, 24(2):85-88.
125. Voit E.O. A First Course in Systems Biology 2012, Garland Science, New York.
126. Voit E.O., Brigham K.L. The role of systems biology in predictive health and personalized medicine. Open Path. J. 2008, 2:68-70.
127. Wertheimer S.P., Barnwell J.W. Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein. Exp. Parasitol. 1989, 69(4):340-350.
128. Westenberger S.J., et al. A systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquito. PLoS Negl. Trop. Dis. 2010, 4(4):e653.
129. White N.J. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar. J. 2011, 10:297.
130. Young M.D. Scientific exploration and achievement in the field of malaria. J. Parasitol. 1966, 52(1):3-8.